Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug Industry Daily > Markey to Hamburg: Will FDA Punish Rogue Compounder?

Drug Industry Daily

Oct. 12, 2012 | Vol. 11 No. 201

Markey to Hamburg: Will FDA Punish Rogue Compounder?

Rep. Edward Markey (D-Mass.) continues to push the FDA for answers about how it will respond to a compounding pharmacy linked to 14 deaths.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
Email This Article
RSS
Free Trial
Archives
Sample PDF

Related Articles

FDA to Hold Two-Day Public Meeting on REMS Challenges Lawmakers Say Gluten Should Be Noted On Drug Labels Ranbaxy Settles cGMP Case With Dept. of Justice FDA to Focus on HIV in Next Patient-Focused Drug Development Meeting

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.